Published in J Cardiovasc Electrophysiol on July 25, 2008
Sudden cardiac death in chronic kidney disease: epidemiology and prevention. Nat Rev Nephrol (2011) 1.17
Prevention of sudden cardiac death in patients with chronic kidney disease. BMC Nephrol (2012) 0.84
A meta-analysis of mortality in end-stage renal disease patients receiving implantable cardioverter defibrillators (ICDs). PLoS One (2014) 0.83
Implantable cardioverter defibrillator efficacy and chronic kidney disease: competing risks of arrhythmic and nonarrhythmic mortality. J Cardiovasc Electrophysiol (2008) 0.82
Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator. J Interv Card Electrophysiol (2012) 0.82
Impact of moderate to severe renal impairment on mortality and appropriate shocks in patients with implantable cardioverter defibrillators. Cardiol Res Pract (2010) 0.78
Implantable cardioverter-defibrillators: indications and unresolved issues. Tex Heart Inst J (2012) 0.77
The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol (2016) 0.76
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75
Implantable cardioverter-defibrillators and chronic kidney disease. J Cardiovasc Electrophysiol (2009) 0.75
Arrhythmic complication in cardiorenal syndrome. Heart Fail Rev (2011) 0.75
Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation. J Interv Card Electrophysiol (2012) 0.75
Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation (2003) 3.97
Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol (2011) 2.98
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation (2013) 2.90
Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling? Am J Med (2012) 2.78
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm (2008) 2.75
Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA (2010) 2.68
Delayed complications following pacemaker implantation. Pacing Clin Electrophysiol (2002) 2.52
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol (2011) 2.48
Acute termination of human atrial fibrillation by identification and catheter ablation of localized rotors and sources: first multicenter experience of focal impulse and rotor modulation (FIRM) ablation. J Cardiovasc Electrophysiol (2012) 2.40
Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol (2010) 2.11
Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm (2004) 2.01
Adenosine facilitates dormant conduction across cavotricuspid isthmus following catheter ablation. Heart Rhythm (2012) 2.00
Cardiac sarcoidosis: contemporary review. J Cardiovasc Electrophysiol (2014) 1.97
Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads. Circulation (2008) 1.96
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 1.87
High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). J Am Coll Cardiol (2004) 1.83
HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm (2008) 1.79
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.79
Characterization of sustained atrial tachycardia in dogs with rapid ventricular pacing-induced heart failure. J Cardiovasc Electrophysiol (2003) 1.78
Contemporary pacemakers: what the primary care physician needs to know. Mayo Clin Proc (2008) 1.75
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm (2008) 1.72
Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation (2006) 1.67
Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace (2012) 1.64
Cardiology patient pages. Cardiac pacemakers from the patient's perspective. Circulation (2002) 1.60
Misdiagnosis of atrial fibrillation and its clinical consequences. Am J Med (2004) 1.58
Atrial activation during atrioventricular nodal reentrant tachycardia: studies on retrograde fast pathway conduction. Heart Rhythm (2006) 1.57
Percutaneous intrapericardial echocardiography during catheter ablation: a feasibility study. Heart Rhythm (2006) 1.57
Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J Cardiovasc Electrophysiol (2014) 1.53
An alternative technique of implanting a nontransvenous implantable cardioverter-defibrillator system in adults with no or limited venous access to the heart. Heart Rhythm (2010) 1.50
Temporal patterns of atrial arrhythmia recurrences in patients with implantable defibrillators: implications for assessing antiarrhythmic therapies. J Cardiovasc Electrophysiol (2002) 1.49
Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure. Heart Rhythm (2006) 1.49
Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy. Pacing Clin Electrophysiol (2009) 1.47
Right ventricular pacing to assess transisthmus conduction in patients undergoing isthmus-dependent atrial flutter ablation: a new useful technique? Heart Rhythm (2006) 1.47
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2012) 1.45
Catheter ablation of chronic atrial fibrillation--the gap between promise and practice. N Engl J Med (2006) 1.43
What is the time course of reversal of tachycardia-induced cardiomyopathy? Europace (2010) 1.43
Inducible supraventricular tachycardias in patients referred for catheter ablation of atrial fibrillation. Europace (2007) 1.43
Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease. J Cardiovasc Electrophysiol (2008) 1.42
Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis of biventricular vs. right ventricular pacing mode. Eur J Heart Fail (2012) 1.42
Diagnosis of high-voltage conductor fractures in Sprint Fidelis leads. Heart Rhythm (2013) 1.42
Acute His-Bundle Injury Current during Permanent His-Bundle Pacing Predicts Excellent Pacing Outcomes. Pacing Clin Electrophysiol (2015) 1.41
Cryoablation inside the pulmonary vein after failure of radiofrequency antral isolation. Heart Rhythm (2007) 1.40
Myocardial ischemia and induction of sustained ventricular tachyarrhythmias: evaluation using dobutamine stress echocardiography-electrophysiologic testing. J Cardiovasc Electrophysiol (2004) 1.39
Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description. J Am Heart Assoc (2013) 1.30
The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart J (2011) 1.25
A comparison of pulmonary vein ostial anatomy by computerized tomography, echocardiography, and venography in patients with atrial fibrillation having radiofrequency catheter ablation. Am J Cardiol (2004) 1.22
Tricyclic antidepressants, QT interval prolongation, and torsade de pointes. Psychosomatics (2004) 1.20
Histopathologic characterization of chronic radiofrequency ablation lesions for pulmonary vein isolation. J Am Coll Cardiol (2012) 1.17
Left ventricular systolic dysfunction induced by ventricular ectopy: a novel model for premature ventricular contraction-induced cardiomyopathy. Circ Arrhythm Electrophysiol (2011) 1.17
Are elderly patients at increased risk of complications following pacemaker implantation? A meta-analysis of randomized trials. Pacing Clin Electrophysiol (2011) 1.17
Pacemaker selection - the changing definition of physiologic pacing. N Engl J Med (2005) 1.14
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace (2015) 1.13
Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm (2009) 1.12
Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol (2003) 1.12
Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol (2009) 1.11